# =============================================================================
# ESTADO DEL SISTEMA - Value Investor v2.2.0
# Actualizado 2026-02-03 - Framework de inversion rediseñado
# =============================================================================

system:
  system_version: "2.2.2"
  last_session: 2026-02-03
  last_session_summary: |
    Sesion 26 - FRAMEWORK DE EVALUACION DE EFECTIVIDAD

    PREGUNTA CLAVE DEL HUMANO:
    "¿Como podemos estar seguros de que conseguiras el beneficio esperado?"

    RESPUESTA HONESTA:
    - NO PODEMOS GARANTIZAR resultados
    - Value investing requiere 2-5 años para validar
    - Hit rate esperado realista: 55-65%, no 100%
    - Win rate actual (7 dias): 28% (muy corto para medir)

    MEJORAS IMPLEMENTADAS:
    1. NUEVO TOOL: tools/effectiveness_tracker.py
       - Win rate, FV hit rate, Sharpe estimado
       - Attribution por sector/geo/tier/holding period
       - Recomendaciones automaticas
       - Ejecutar CADA sesion

    2. NUEVO SKILL: effectiveness-evaluation
       - Metricas por horizonte (semanal/mensual/trimestral/anual)
       - Protocolo de revision
       - Registro obligatorio de errores

    3. CLAUDE.md ACTUALIZADO:
       - Error #23: No tener sistema de evaluacion de efectividad
       - Error #24: Asumir que value investing funciona sin validacion
       - Protocolo inicio: ahora incluye effectiveness_tracker.py
       - Tool documentado en seccion de tools

    4. AUDITORIA COMPLETA DE CONSISTENCIA:
       - 19 agentes: OK (16 principales + 3 micro)
       - 22 skills: OK (todos referenciados)
       - 7 tools: OK (todos documentados)
       - 18 posiciones = 18 thesis: OK
       - Sistema CONSISTENTE

    METRICAS ACTUALES (7 dias, estadisticamente irrelevante):
    - Portfolio: EUR 9,623 | Cash 17.1% (DRAG)
    - P&L total: -0.2% (flat)
    - Win rate: 28% (bajo, pero solo 7 dias)
    - Sharpe: -0.30 (negativo, pero muy corto plazo)

    CONSTRAINT VIOLATIONS (sin cambios):
    - TEP.PA: 7.9% > 7% max
    - DTE.DE: 7.0% (borderline)
    - EU geo: 36.6% > 35% max

    PENDIENTE PROXIMA SESION (27):
    1. TRIM TEP.PA: 4 shares (~EUR 216) - CRITICO
    2. PFE earnings call 10am EST hoy - verificar resultados
    3. Earnings 5-Feb: GL, ALL, SHEL.L, EVO.ST
    4. Desplegar cash (17.1% > 15% target)
    5. Standing orders cercanos: ZIG.L (2.8%), BME.L (3.3%)

    ---
    Sesion 25 - RE-EVALUACION COMPLETA PORTFOLIO CON FRAMEWORK v2.0

    **18/18 POSICIONES RE-EVALUADAS:**
    | Posicion | FV Change | MoS v2.0 | Value Trap | Status |
    |----------|-----------|----------|------------|--------|
    | PFE | -20% | 3% | 2/10 | HOLD |
    | ALL | = | 16% | N/A | HOLD |
    | SHEL.L | -18% | -4% | 0/10 | HOLD |
    | VICI | +2% | 17% | 0/10 | HOLD |
    | VNA.DE | -10% | 25% | 0-1/10 | HOLD |
    | IMB.L | = | 20% | 1/10 | HOLD |
    | DTE.DE | +2% | 27-32% | 0/10 | HOLD |
    | A2A.MI | -25% | 6% ⚠️ | 1-2/10 | HOLD |
    | DOM.L | +9% | 38% | 0.5/10 | HOLD |
    | SAN.PA | +20% | 34% | 0/10 | HOLD |
    | HRB | +17% | 54% | 2-3/10 | HOLD |
    | LIGHT.AS | +28% | 45% | 2.5/10 | HOLD |
    | TATE.L | +10% | 31% | 2/10 | HOLD |
    | EDEN.PA | +43% | 47% | 0-1/10 | HOLD |
    | FUTR.L | -8% | 46-53% | 4/10 ⚠️ | HOLD |
    | UHS | -9% | 29% | 1.5/10 | HOLD |
    | TEP.PA | -4% | 49% | 1/10 | TRIM |
    | GL | -19% | 18% | 0/10 | HOLD |

    HALLAZGOS CLAVE:
    - Framework v2.0 mas conservador en ~50% de posiciones
    - 8 posiciones con FV mayor (SAN, HRB, LIGHT, TATE, EDEN, DOM, DTE, VICI)
    - A2A.MI: MoS solo 6% (DCF inapropiado, FCF negativo temporal)
    - FUTR.L: 4/10 value trap factors (alto riesgo, pero MoS compensa)

    CONSTRAINT VIOLATIONS:
    - TEP.PA: 8.1% > 7% max → TRIM 2 shares pendiente
    - FUTR.L: 7.2% > 7% max → borderline
    - EU geo: 36.7% > 35% max

    PFE EARNINGS (3-Feb): FY2026 guidance $2.80-3.00 INLINE, dividend MAINTAINED.

    MEJORAS SISTEMA:
    - CLAUDE.md: errores #21, #22 documentados
    - Creado skill: re-evaluation-protocol
    - Actualizado review-agent a v2.0
    - 18 thesis y 18 journal reviews creados

    PROXIMA SESION (26) - CONTINUAR DESDE AQUI:
    1. TRIM TEP.PA: Vender 2 shares (~€112) para bajar de 8.1% a 6.5%
    2. Revisar standing orders con nuevo framework v2.0
    3. Revision global portfolio y toma de decisiones
    4. Probar framework v2.0 con nueva investigacion (screening fresco)

    EARNINGS PROXIMOS (5-Feb-2026):
    - ALL: Q4 2025 - watch combined ratio
    - SHEL.L: Q4 2025 - watch FCF, buyback
    - GL: Q4 2025 - watch EPS $3.44 consensus

    Sesion 24 - REDISENO COMPLETO DEL FRAMEWORK DE INVERSION

    CAMBIO MAYOR ESTRATEGICO:
    El humano y yo identificamos que el sistema compraba "estadisticamente barato" sin:
    - Entender el negocio profundamente (unit economics, modelo)
    - Saber POR QUE esta barata (narrativa del mercado vs mi contra-tesis)
    - Proyectar con logica (usabamos defaults 5% growth, 9% WACC)
    - Usar multiples metodos de valoracion (solo DCF)
    - Conectar macro con decisiones de compra

    IMPLEMENTADO:
    1. 3 NUEVOS SKILLS:
       - business-analysis-framework: Unit economics, modelo negocio, por que barata, value trap checklist
       - projection-framework: TAM/share/pricing → growth, WACC calculado, NO defaults
       - valuation-methods: Multiples metodos segun tipo empresa (DCF, EV/EBIT, NAV, DDM, P/B vs ROE)

    2. 4 SKILLS ACTUALIZADOS (v2.0):
       - investment-rules: 7 gates obligatorios, reglas de venta claras, sizing dinamico
       - thesis-template: Business understanding, proyecciones, escenarios Bear/Base/Bull
       - decision-template: Checklist expandido con todos los gates
       - moat-framework: Evidencia cuantitativa obligatoria

    3. 4 AGENTES ACTUALIZADOS (v2.0):
       - fundamental-analyst: 5 fases obligatorias
       - valuation-specialist: Metodo segun tipo empresa
       - investment-committee: 7 gates obligatorios
       - macro-analyst: Output ACCIONABLE conectado con decisiones

    4. CLAUDE.md actualizado con:
       - Nueva seccion v2.2.0 explicando el cambio
       - Flujo de inversion de 5 capas
       - 4 nuevos errores recurrentes documentados (#16-19)

    PORTFOLIO: Sin cambios operativos esta sesion (foco en framework)
    - 18 posiciones, cash €1,647 (17%)

    PROXIMA SESION (26):
    - Continuar re-evaluacion portfolio restante (14 posiciones)
    - GL: Monitorear Q4 2025 earnings Feb 5
    - ALL + SHEL.L earnings Feb 5 tambien
    - Ejecutar TRIMs pendientes si confirmados
  status: active

# -----------------------------------------------------------------------------
# CALENDARIO
# -----------------------------------------------------------------------------
calendar:
  events:
    # WEEK OF FEB 3-7
    - date: 2026-02-03
      type: action_completed
      ticker: SHEL
      event: "DONE - TRIM SHEL: vender 10 acciones"
      priority: CRITICAL
      action: "SELL 10 shares SHEL en eToro. 20.85→10.85. Rebalanceo 13%→7%."

    - date: 2026-02-03
      type: action_completed
      ticker: A2A.MI
      event: "DONE - BUY A2A.MI ~134 shares"
      priority: CRITICAL
      action: "BUY ~134 shares A2A.MI ~€2.54. Total ~€340 (4%). Max entry €2.80."

    - date: 2026-02-03
      type: action_completed
      ticker: EDEN.PA
      event: "DONE - BUY EDEN.PA ~22 shares"
      priority: CRITICAL
      action: "BUY ~22 shares EDEN.PA ~€17.67. Total ~€400 (4%). FV €33-36."

    - date: 2026-02-03
      type: action_completed
      ticker: VNA.DE
      event: "DONE - BUY VNA.DE ~16 shares"
      priority: CRITICAL
      action: "BUY ~16 shares VNA.DE ~€24.61. Total ~€400 (4%). FV €35-38."

    - date: 2026-02-03
      type: earnings
      ticker: PFE
      event: "Pfizer Q4 2025 (pre-market)"
      priority: high
      action: "Watch: EPS $0.57, FY2026 guidance, dividendo. Beat+OK→HOLD. Miss+div cut→SELL."

    - date: 2026-02-05
      type: earnings
      ticker: GL
      event: "Globe Life Q4 2025 (after market close)"
      priority: high
      action: "Watch: EPS $3.44 consensus, FY2026 guidance. If beat → may re-rate. If miss → evaluate position. MoS at $143 = 17.6%."

    - date: 2026-02-05
      type: earnings
      ticker: ALL
      event: "Allstate Q4 2025"
      priority: high
      action: "Watch combined ratio Q4, guidance 2026 mid-90s, PIF growth."

    - date: 2026-02-05
      type: earnings
      ticker: SHEL.L
      event: "Shell Q4 2025"
      priority: high
      action: "Watch FCF, buyback $3.5B, guidance."

    - date: 2026-02-05
      type: action
      ticker: EVO.ST
      event: "POST-EARNINGS: Evaluar compra Evolution AB"
      priority: high
      action: "Si buenos + UKGC OK → BUY hasta 650 SEK (~€400). Si malos → 480-530 SEK. Si UKGC revocacion → DESCARTAR."

    - date: 2026-02-03
      type: action_completed
      ticker: TATE.L
      event: "DONE - BUY TATE.L 66 shares"
      priority: high
      action: "Bought 66 shares TATE.L, $339.73 invested. Starter position 2.7%."

    - date: 2026-02-02
      type: action_completed
      ticker: DOM.L
      event: "DONE - BUY DOM.L 175 shares"
      priority: high
      action: "Bought 175 shares DOM.L, $436.52 invested. Master franchisee, 54% UK market share."

    - date: 2026-03-05
      type: earnings
      ticker: DOM.L
      event: "Domino's Pizza Group FY25 results"
      priority: high
      action: "Review EBITDA guidance, FCF, dividend policy, CEO appointment timeline. Kill conditions: ND/EBITDA >3x, FCF <60M, share <45%."

    - date: 2026-02-02
      type: action_completed
      ticker: UHS
      event: "DONE - BUY UHS 2 shares"
      priority: high
      action: "Bought 2 shares UHS, $402.84 invested. Behavioral health leader, P/E 9.6x."

    - date: 2026-02-26
      type: earnings
      ticker: UHS
      event: "UHS Q4 2025 / FY2025 earnings (estimated)"
      priority: high
      action: "Watch: EPS vs $21.80 consensus, behavioral health volumes, labor costs, Medicaid impact. Kill: ROIC<WACC 2Q, BH volumes decline YoY."

    - date: 2026-02-07
      type: action_completed
      ticker: DTE.DE
      event: "TRIM DTE.DE ejecutado 2026-02-03: vendidas 14 shares, posicion reducida a 7%"

    - date: 2026-02-11
      type: earnings
      ticker: CVS
      event: "CVS Health Q4 2025"
      priority: high
      action: "BEAT (EPS >$6.70, margin >8%) → ready_to_buy €300. MISS → descartar."

    - date: 2026-02-19
      type: earnings
      ticker: AGN.NV
      event: "Aegon FY2025"
      priority: high
      action: "Watch OCG €1.2B, solvency >180%. Si precio cae €5.90 → BUY."

    - date: 2026-02-23
      type: strategy
      ticker: ENEL.MI
      event: "Enel Capital Markets Day"
      priority: high
      action: "Si FV sube €11-12 → entry €8.50."

    - date: 2026-02-26
      type: earnings
      ticker: DTE.DE
      event: "Deutsche Telekom FY2025"
      priority: high
      action: "Watch FCF, EBITDA, guidance 2026."

    - date: 2026-02-26
      type: earnings
      ticker: CS.PA
      event: "AXA FY2025 results"
      priority: high
      action: "Si precio cae a €34.50-35.50 post-earnings → BUY 5% (~€500). Combined ratio <90% + guidance OK = compra."

    - date: 2026-02-27
      type: earnings
      ticker: PROX.BR
      event: "Proximus FY2025 + Strategic Plan"
      priority: high
      action: "Si capex decline confirmado + plan Global creible → BUY 3% (~€300) a €7.50-7.70. Si decepcionante → AVOID hasta €5-6."

    - date: 2026-02-28
      type: earnings
      ticker: ENGI.PA
      event: "Engie FY2025"
      priority: high
      action: "Watch FCF yield >5%, payout <80%, Debt/EBITDA <4x."

    - date: 2026-03-01
      type: earnings
      ticker: NTGY.MC
      event: "Naturgy FY2025"
      priority: high
      action: "Watch dividend, FCF, Debt/EBITDA <4x."

    - date: 2026-03-19
      type: earnings
      ticker: ENEL.MI
      event: "Enel FY2025 results"
      priority: medium

# -----------------------------------------------------------------------------
# WATCHLIST
# -----------------------------------------------------------------------------
watchlist:
  ready_to_buy:
    - ticker: TTE
      target_entry_eur: 45
      fair_value_eur: 60-83
      margin_of_safety: 26%
      sizing: "€1,170 (7%)"
      status: "WAIT - current ~€61 = 0% MoS. Need earnings + correction."
      thesis: thesis/watchlist/TTE/thesis.md

    - ticker: LGEN.L
      target_entry_gbp: 215
      sizing: "€1,170 (7%)"
      status: "ON WATCH - wait FY2025 results"
      notes: "P/E ~10x, yield 8.5%, BofA 17.5% capital return"

    - ticker: EVO.ST
      target_entry_sek: 480-650
      fair_value_sek: 1009
      margin_of_safety: 42.6%
      sizing: "€400 (4%)"
      status: "WAIT earnings 5-feb"
      thesis: thesis/research/EVO.ST/thesis.md


  tier_2:
    - ticker: AGN.NV
      entry: "€5.90-6.10"
      notes: "P/E 7.4x, yield 5.8%. Borderline MoS. Earnings 19-Feb."
    - ticker: MBG.DE
      entry: "€48-52"
      notes: "Current €57. Need 30%+ MoS. Q4 earnings catalyst."
    - ticker: CS.PA
      entry: "€34.50-35.50"
      notes: "AXA. Tier A (8/10). FV €40.50. Wide moat. Solvency 222%. WAIT FY2025 earnings 26-feb."
    - ticker: ORA.PA
      entry: "€13-14"
      notes: "Orange. Current €15.62 above old target. P/E 41x = expensive. Needs re-evaluation or REMOVE."
    - ticker: RIO.L
      entry: "£120"
      notes: "Materials diversification. Lithium pivot."
    - ticker: ENGI.PA
      entry: "€22"
      notes: "Yield 6.6%. Needs fundamental analysis."
    - ticker: NTGY.MC
      entry: "€19-21"
      notes: "Yield conflict. Needs data validation."
    - ticker: CMCSA
      entry: "$25-26"
      notes: "FV $33-38 (adjusted for normalized FCF + $90B debt). Broadband moat ERODING (FWA, fiber). Peacock -$500M/Q. Theme parks bright spot. NO BUY at $29.75."
    - ticker: GIS
      entry: "$34-38"
      notes: "DCF ~$41. D/E 147%, GLP-1 headwind."
    - ticker: AZM.MI
      entry: "€32-33"
      notes: "Asset manager. P/E 9.8x, yield 4.9%, D/E 0.01. Narrow moat. FV €42-44. Strong buy €30."
    - ticker: PROX.BR
      entry: "€7.50-7.70"
      notes: "Telecom belga. EV/EBITDA 3.1x. FV €12 base. WAIT strategic plan 27-feb. DIGI risk."

  on_watch:
    - ticker: ENEL.MI
      entry: "€7.00-7.50"
      notes: "Vendida breakeven. CMD 23-feb catalyst."
    - ticker: CVS
      entry: "$70"
      notes: "Turnaround. Q4 11-feb binary event."
    - ticker: AMT
      entry: "$160-165"
      notes: "Infrastructure REIT. Debt/EBITDA 6.18x."
    - ticker: IBE.MC
      entry: "€14-15"
      notes: "Quality but P/E 21-24x premium."
    - ticker: ADM.L
      entry: "£24-26"
      notes: "ROE 56% but margin -16%."
    - ticker: 8001.T
      entry: "¥6,500 ($43)"
      notes: "Itochu. Quality premium in price."
    - ticker: TATE.L
      entry: "375 GBp (starter BOUGHT), 350 GBp add, 325 GBp full position"
      fair_value: "500 GBp"
      kill: "Dividend cut, ND/EBITDA >3x, EBITDA margin <17%"
    - ticker: DGE.L
      entry: "2400-2500 GBp"
      notes: "Diageo. Wide moat beverages. Fwd P/E 13x, yield 4.8%. Payout ~100% = risk. Earnings 25-feb. Analyze post-earnings."
    - ticker: BME.L
      entry: "169 GBp"
      notes: "B&M discount retail. FV 260p. At 169p = 35% MoS Tier C. Or wait H2 June 2026. D/E high (IFRS16). Narrow moat."
    - ticker: TBCG.L
      entry: "3500 GBp"
      notes: "TBC Bank Georgia. ROE 24%, P/E 6.6x. MoS 21% at 4265 = FAIL Tier C. At 3500 = 35% MoS. Max 4%. Frontier risk."
    - ticker: BGEO.L
      entry: "7000 GBp"
      notes: "Lion Finance (ex-Bank of Georgia). P/E 7.9x, ROE 29%. Near 52w high (9975 vs 10230). NO discount. Wait -30% correction. Same Georgia risk as TBCG."
    - ticker: WPP.L
      entry: "200 GBp"
      notes: "Value trap at current 297p. No moat, AI disruption, Altman Z 1.06. Only at 200p (35% MoS). Review Q3 results + CEO plan."
    - ticker: UTG.L
      entry: "540 GBp"
      fair_value: "770 GBp"
      notes: "Unite Group. UK student REIT, 42% discount to NAV 986p. FY2026 earnings guided down 7-10%. Occupancy 95.2% falling. At 540p = 30% MoS. BBB+, LTV 26%."
      kill: "Occupancy <90%, dividend cut, LTV >35%, immigration policy kills int'l student demand"
    - ticker: HPQ
      entry: "$17-18"
      fair_value: "$27"
      notes: "HP Inc. FCF yield 13.2%, P/E 7.3x. Cash machine but printing in secular decline. MoS 28% borderline. Wait FY26 Q1 late-Feb. Baja conviccion."
      kill: "Printing revenue decline >15% annual, dividend cut, FCF <$2B"
    - ticker: MEGP.L
      entry: "131 GBp"
      fair_value: "175 GBp"
      notes: "ME Group. ROE 31.8%, EBITDA margin 37%, net cash, monopoly laundry kiosks. Only 2 analysts. At 131p = 25% MoS. FY2025 results mid-Feb catalyst."
      kill: "German photo regulation kills Photo.ME division, laundry growth stalls <10%"

  active_monitoring:
    - ticker: A2A.MI
      entry: 2.548
      fair_value: 3.62
      kill: "FCF decline >15% or dividend cut"
    - ticker: EDEN.PA
      entry: 17.61
      fair_value: 33-36
      kill: "FCF <€300M or revenue decline >10%"
    - ticker: VNA.DE
      entry: 24.55
      fair_value: 35-38
      kill: "FFO/share decline >15% or dividend cut"
    - ticker: DTE.DE
      entry: 31.85
      fair_value: 58-74
      kill: "T-Mobile US spin-off fails or EBITDA decline >10%"
    - ticker: SHEL.L
      entry_usd: 36.72
      fair_value_usd: 45-55
      kill: "Dividend cut or FCF <$20B sustained"
    - ticker: PFE
      entry_usd: 26.75
      fair_value_usd: 32-35
      kill: "Dividend cut or FY2026 guidance miss >10%"
    - ticker: ALL
      entry_usd: 196.00
      fair_value_usd: 240-260
      kill: "Combined ratio >100% sustained or catastrophe losses >$5B"
    - ticker: TEP.PA
      entry: 54.60
      fair_value: 115
      kill: "FCF <€600M or revenue -5%"
    - ticker: SAN.PA
      entry: 79.20
      fair_value: 95-105
      kill: "Dividend cut or 2+ trial failures"
    - ticker: VICI
      entry_usd: 28.08
      fair_value_usd: 34-35
      kill: "Dividend cut or tenant bankruptcy"
    - ticker: IMB.L
      entry_usd: 42.34
      fair_value_usd: 44-52
      kill: "Dividend cut or buyback suspension"
    - ticker: LIGHT.AS
      entry: 17.91
      fair_value: 26.73
      kill: "FCF <€300M or revenue -10%"
    - ticker: TATE.L
      entry: 375
      fair_value: 500
      kill: "Dividend cut, ND/EBITDA >3x, EBITDA margin <17%"
    - ticker: DOM.L
      entry: 183
      fair_value: 260-280
      kill: "Net Debt/EBITDA >3x, FCF <60M, market share <45%, dividend cut"
    - ticker: UHS
      entry_usd: 201.42
      fair_value_usd: 270-313
      kill: "ROIC < WACC 2 consecutive quarters, behavioral health volumes decline YoY, Medicaid cuts >$100M"
    - ticker: GL
      entry_usd: 141.06
      fair_value_usd: 174
      fair_value_original: 215
      fair_value_v2: 174
      mos_v2: 17.6%
      notes: "Framework v2.0 re-eval: P/B vs ROE + P/E normalized. 0/10 value trap. Beta 0.46. Quality 7/10 Tier B. MoS below 25% threshold → HOLD, no ADD."
      kill: "Operating EPS <$12, or class action reveals material new fraud evidence"
      buy_trigger: "$130 or below (MoS would be 25.3%)"
    - ticker: FUTR.L
      entry_gbp: 532
      fair_value_gbp: 1100-1200
      kill: "Revenue decline >10% 2+ years, margins <20%, buyback suspension"

# -----------------------------------------------------------------------------
# ALERTAS DE PRECIO
# -----------------------------------------------------------------------------
alerts:
  price_monitors:
    - { ticker: TTE, entry_eur: 45, note: "FV €60. Wait earnings+correction" }
    - { ticker: LGEN.L, entry_gbp: 215, note: "FV ~265p. Wait FY2025" }
    - { ticker: MBG.DE, entry_eur: 50, note: "FV €70. Cyclical wait" }
    - { ticker: ENEL.MI, entry_eur: 7.50, note: "Re-entry. CMD 23-feb" }
    - { ticker: AGN.NV, entry_eur: 5.90, note: "Borderline. Earnings 19-Feb" }
    - { ticker: CVS, entry_usd: 70, note: "Q4 11-feb binary" }
    - { ticker: T, entry_usd: 22.50, note: "FCF $18B+. Best US telecom" }
    - { ticker: BNP.PA, entry_eur: 78, note: "FV €103. CET1 12.5%" }
    - { ticker: ENGI.PA, entry_eur: 22, note: "FV €29. Yield 6%" }
    - { ticker: CS.PA, entry_eur: 35.50, note: "AXA. FV €40.50. Tier A. Earnings 26-feb" }
    - { ticker: BME.L, entry_gbp: 169, note: "B&M Retail. FV 260p. Tier C turnaround." }
    - { ticker: TBCG.L, entry_gbp: 3500, note: "TBC Bank Georgia. FV 5400p. Frontier Tier C." }
    - { ticker: BGEO.L, entry_gbp: 7000, note: "Lion Finance (ex-BOG). Near ATH, wait correction." }
    - { ticker: WPP.L, entry_gbp: 200, note: "Value trap. Only at 200p with turnaround evidence." }
    - { ticker: TATE.L, entry_gbp: 350, note: "ADD to starter. FV 500p. Already own 66 shares." }
    - { ticker: DGE.L, entry_gbp: 2450, note: "Diageo. Wide moat. Wait earnings 25-feb." }
    - { ticker: EVO.ST, entry_sek: 530, note: "Evolution. If Q4 miss → buy 480-530 SEK." }
    - { ticker: GL, entry_usd: 130, note: "Globe Life ADD trigger. At $130 MoS=25.3%. Do not add >$130." }

# -----------------------------------------------------------------------------
# STANDING ORDERS (pre-aprobadas, ejecutar cuando precio toque trigger)
# El humano puede ejecutar en eToro sin esperar sesion.
# En siguiente sesion confirma y se actualiza portfolio.
# -----------------------------------------------------------------------------
standing_orders:
  # THESIS COMPLETA + COMMITTEE APROBADO — Solo falta que precio llegue
  - ticker: BME.L
    action: BUY
    trigger: "<=169 GBp"
    size_eur: 400
    shares_approx: 235
    thesis: thesis/research/BME.L/thesis.md
    fair_value: "260 GBp"
    mos_at_trigger: "35%"
    notes: "B&M discount retail. Narrow moat. Tier C. Committee: WATCHLIST at 175p, BUY at 169p."
    expiry: 2026-04-01

  - ticker: MEGP.L
    action: BUY
    trigger: "<=131 GBp"
    size_eur: 400
    shares_approx: 265
    thesis: thesis/research/MEGP.L/thesis.md
    fair_value: "175 GBp"
    mos_at_trigger: "25%"
    notes: "ME Group. 2 analysts, monopoly laundry kiosks. ROE 31.8%. FY2025 mid-Feb catalyst."
    expiry: 2026-04-01

  - ticker: UTG.L
    action: BUY
    trigger: "<=540 GBp"
    size_eur: 400
    shares_approx: 64
    thesis: thesis/research/UTG.L/thesis.md
    fair_value: "770 GBp"
    mos_at_trigger: "30%"
    notes: "Unite Group UK student REIT. 42% discount NAV. Earnings declining FY2026."
    expiry: 2026-04-01

  - ticker: TATE.L
    action: ADD
    trigger: "<=350 GBp"
    size_eur: 350
    shares_approx: 87
    thesis: thesis/active/TATE.L/thesis.md
    fair_value: "500 GBp"
    mos_at_trigger: "30%"
    notes: "ADD to existing 66 shares. Brings position from 3.1% to ~6%."
    expiry: 2026-04-01

  - ticker: DGE.L
    action: BUY
    trigger: "<=1700 GBp + earnings 25-feb OK (no div cut, ND/EBITDA declining)"
    size_eur: 450
    shares_approx: 23
    thesis: thesis/research/DGE.L/thesis.md
    fair_value: "2100-2200 GBp"
    mos_at_trigger: "25-31%"
    notes: "Diageo. Wide moat Tier A. CONDICIONAL a earnings 25-feb. Si div cut → CANCELAR."
    expiry: 2026-03-15

  - ticker: ZIG.L
    action: BUY
    trigger: "<=375 GBp"
    size_eur: 350
    shares_approx: 81
    thesis: thesis/research/ZIG.L/thesis.md
    fair_value: "500 GBp"
    mos_at_trigger: "25%"
    notes: "Zigup fleet management. 5 analysts, yield 6.9%, fwd P/E 7x. Ideal entry <=350p (30% MoS)."
    expiry: 2026-05-01

  # GL ADD - CONDITIONAL on price pullback
  - ticker: GL
    action: ADD
    trigger: "<=$130"
    size_eur: 300
    shares_approx: 2
    thesis: thesis/active/GL/thesis.md
    fair_value: "$174"
    mos_at_trigger: "25.3%"
    notes: "Globe Life. Framework v2.0 FV $174. At $130 reaches 25% MoS. Current $143 = 17.6% MoS (insufficient). Quality 7/10 Tier B."
    expiry: 2026-06-01

  # PENDIENTE EARNINGS — Ejecutar SOLO si earnings cumplen condiciones
  - ticker: EVO.ST
    action: BUY
    trigger: "<=650 SEK + Q4 beat + UKGC OK"
    size_eur: 400
    shares_approx: 7
    thesis: thesis/research/EVO.ST/thesis.md
    fair_value: "1009 SEK"
    notes: "CONDICIONAL a earnings 5-feb. Si UKGC revocacion → CANCELAR."
    expiry: 2026-02-15

  - ticker: HPQ
    action: BUY
    trigger: "<=$18.50"
    size_eur: 400
    shares_approx: 21
    thesis: thesis/research/HPQ/thesis.md
    fair_value: "$27"
    mos_at_trigger: "31.5%"
    notes: "HP Inc. Committee: WATCHLIST at $19.84, BUY at $18.50. Wait FY26 Q1 earnings late-Feb. Printing decline key risk."
    expiry: 2026-04-01

  - ticker: FGP.L
    action: BUY
    trigger: "<=165 GBp"
    size_eur: 400
    shares_approx: 209
    thesis: thesis/research/FGP.L/thesis.md
    fair_value: "220-240 GBp"
    mos_at_trigger: "25%"
    notes: "FirstGroup. UK bus/rail. P/E 9x, 4 analysts all Buy. Narrow moat. IFRS16 distorts FCF."
    expiry: 2026-06-01

  - ticker: BBWI
    action: BUY
    trigger: "<=$18.50"
    size_eur: 400
    shares_approx: 21
    thesis: thesis/research/BBWI/thesis.md
    fair_value: "$29"
    mos_at_trigger: "36%"
    notes: "Bath & Body Works. Tier C turnaround. $5B debt, negative equity. FCF $660M (14% yield). Monitor Q4 Feb 19."
    expiry: 2026-04-01

  - ticker: CMCSA
    action: BUY
    trigger: "<=$26"
    size_eur: 450
    shares_approx: 15
    thesis: thesis/research/CMCSA/thesis.md
    fair_value: "$33-38"
    mos_at_trigger: "26-31%"
    notes: "Comcast. Tier B. Broadband declining, theme parks star. $95B net debt. P/E 5.5x misleading (fwd 7.5x). Watch broadband losses."
    expiry: 2026-06-01

  - ticker: WPP.L
    action: BUY
    trigger: "<=200 GBp"
    size_eur: 400
    shares_approx: 173
    thesis: thesis/research/WPP.L/thesis.md
    fair_value: "360 GBp"
    mos_at_trigger: "44%"
    notes: "WPP turnaround. Tier C. No moat, AI disruption. Altman Z 1.06. Wait for Rose plan Feb 19."
    expiry: 2026-04-01

# -----------------------------------------------------------------------------
# MACRO (resumen)
# -----------------------------------------------------------------------------
macro_snapshot:
  last_update: 2026-02-02
  themes: ["Fed/BCE pausa 3.5%/2.0%", "Europa barata", "Tariffs escalando (Corea 25%, Canada amenaza)", "Iran tension ↑", "China mejora IMF 4.5%", "Alemania sale recesion"]
  risks: ["US-Iran guerra regional 30-40% (↑)", "US-China Taiwan 10-20%", "Tariff war global 40-50%", "Recesion US 25-35%", "Oil shock >$90 si Iran 15-25%"]

# -----------------------------------------------------------------------------
# MANTENIMIENTO
# -----------------------------------------------------------------------------
maintenance:
  last_health_check: 2026-02-01
  next_health_check_due: 2026-02-15
  health_score: 9.1/10
  last_compact: 2026-02-01
  memory_status: ok
  agents_count: 19
  evolution_tracking:
    last_evaluation: 2026-02-01
    applied:
      - "2026-02-01: Fusion self-evolution+evolution-manager → system-evolver"
      - "2026-02-01: health-check upgraded haiku→sonnet, +quantitative checks"
      - "2026-02-01: TTE moved active→watchlist"
      - "2026-02-01: system.yaml compacted 863→~350 lines"
    pending:
      - "Continuar re-evaluacion: 14 posiciones restantes"
      - "Crear skill/protocolo de re-evaluacion v2.0"
    applied_2026_02_03_session25:
      - "Re-evaluacion PFE: FV $27.52 (era $32-35), MoS 3-10% (era 25-36%) → FAIRLY VALUED"
      - "Re-evaluacion ALL: FV $240 (confirmado), MoS 16% (era 21%) → MODERATELY UNDERVALUED"
      - "Re-evaluacion SHEL.L: FV £26.8 (era £32-35), MoS -4% (era 25-30%) → FAIRLY VALUED"
      - "Re-evaluacion GL: FV $174 (era $215), MoS 17.6% (era 34%) → HOLD (was BUY). P/B vs ROE method."
      - "Framework v2.0 es ~20pp mas conservador que analisis original"
      - "3/4 posiciones no habrian pasado filtro inicial con v2.0"
      - "Fixed: LIGHT.AS ticker, HRB standing order removed"
      - "CLAUDE.md actualizado: errores #21 (current_view primero), #22 (usar agentes)"
      - "Creado skill: re-evaluation-protocol"
      - "Actualizado review-agent a v2.0 (anadidos skills framework)"
      - "PFE earnings HOY: FY2026 guidance $2.80-3.00 EPS INLINE, div MANTENIDO"
      - "15 review-agents lanzados en paralelo para re-evaluar posiciones restantes"
      - "GL review: thesis updated v2.0, journal entry created"
    applied_2026_02_02:
      - "Fixed SHEL→SHEL.L ticker bug (+$427 phantom value)"
      - "Fixed dcf_calculator.py GBp/GBP mismatch for LSE stocks"
      - "Portfolio fully synced with eToro (13 positions)"
      - "Added 8 new price monitors"
      - "Moved A2A.MI, EDEN.PA, VNA.DE, TATE.L thesis to active"
      - "7 fundamental analyses: WPP(reject), BME(watch), TATE(buy), CMCSA(watch), TBCG(watch), BGEO(watch), screening(complete)"
